With the increase in the pace of life, the increase in social pressure and the increase in people’s irregular lifestyle, the incidence of sudden deafness has been increasing significantly. However, there are many patients who have already been treated in other hospitals for more than a month after the onset of the disease, and it is very difficult to treat them again because they have already missed the best treatment period. Sudden deafness is different from other diseases that affect the hearing. It is an acute disease with a sudden onset, hence the name sudden deafness. The onset is particularly common in one ear. The earlier the treatment, the better. And it is important to choose the appropriate medication according to the etiology of the condition and the type of hearing damage, rather than a one-size-fits-all approach. In patients with severe deafness, early use of hormonal agents is emphasized and the amount should vary from person to person, especially in patients with underlying diseases such as diabetes and hypertension. The use of hormones should also be administered in different ways depending on the stage of the disease. Therefore, there are many new ideas and approaches in the treatment of this disease in recent years, and if the receiving physician has little knowledge of these new ideas, he or she is likely to miss the best time and medication for treatment, and if the onset of the disease is more than 3 months, the chances of improving the symptoms with medication are theoretically very low. This is quite similar to the treatment of facial nerve palsy, and should be given sufficient attention by patients, and timely treatment is especially critical. There are several theories about the etiology of the disease. Such as infection theory, microcirculatory disorders theory, autoimmune theory, etc.. The most commonly accepted cause is the microcirculatory disorder theory, because there is only one terminal artery supplying the inner ear, the internal auditory artery, which branches off from the anterior inferior cerebellar artery and has no collateral circulation. A spasm or embolism of this artery will have an immediate and severe impact on inner ear function. This can lead to clinical symptoms such as hearing loss, tinnitus, and dizziness. The symptoms may vary from patient to patient, but the common denominator is definitely hearing loss, but there are differences in hearing loss, such as high frequency hearing loss, low frequency hearing loss, and full frequency hearing loss. There are also differences in treatment. Therefore, hearing examination is a must for patients, and otoacoustic emission examination should be performed to determine the function of the cochlea, vestibular function examination should also be selected for patients with dizziness symptoms, and many patients who consult neurology, doctors often recommend brain CT cerebral angiography cervical spine CT Doppler ultrasound examination, etc. In fact, these tests are not only time-consuming and costly, there is little meaning, but also Because of the appointment check queue and other results delayed for several days, for the treatment of the disease means that the most valuable time for treatment is lost, so the doctor’s experience is crucial, should have a high sensitivity to the disease, pay attention to exclude the disease, because many patients if the hearing damage is not very serious at the beginning of the complaint symptoms are often some other insignificant symptoms, easy to mislead the doctor. Even otolaryngologists often misdiagnose and mismanage cases, such as cerumen embolism, otitis media, and tympanic membrane invagination. In my outpatient work, I often encounter patients who are misdiagnosed. Therefore, this disease should first be treated with a clear diagnosis and early pharmacological intervention, and sometimes even if tests cannot be performed (e.g., many hospitals do not have audiology-related tests on weekends), treatment should precede with a clear pathogenic feature, i.e., sudden hearing loss. According to my experience in the last two years, as long as the onset of the disease has not exceeded 3 months, after appropriate pharmacological treatment, especially the proper selection of hormones (including preparations and routes of administration), nearly half of the patients can still receive significant therapeutic effects, with hearing improvement being particularly obvious. The only thing that should be emphasized is to choose the most reasonable medication from experienced doctors. This is the current international consensus in the treatment of this disease.